

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenylpropanoid metabolic process (GO:0009698) | 8.36478447 |
| 2 | urea metabolic process (GO:0019627) | 8.34054878 |
| 3 | urea cycle (GO:0000050) | 8.08372107 |
| 4 | nitrogen cycle metabolic process (GO:0071941) | 7.56994782 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.51373682 |
| 6 | serine family amino acid catabolic process (GO:0009071) | 7.47197366 |
| 7 | protein carboxylation (GO:0018214) | 7.46884259 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.46884259 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 7.22023827 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 7.02246754 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.02246754 |
| 12 | regulation of protein activation cascade (GO:2000257) | 6.94092181 |
| 13 | oxidative demethylation (GO:0070989) | 6.55156792 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 6.48806439 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.43530289 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 6.43149668 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.43149668 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 6.39159568 |
| 19 | glycine metabolic process (GO:0006544) | 6.38117496 |
| 20 | drug catabolic process (GO:0042737) | 6.34679710 |
| 21 | hormone catabolic process (GO:0042447) | 6.24560013 |
| 22 | complement activation, alternative pathway (GO:0006957) | 6.05148850 |
| 23 | regulation of complement activation (GO:0030449) | 5.93024916 |
| 24 | fibrinolysis (GO:0042730) | 5.92872927 |
| 25 | alkaloid metabolic process (GO:0009820) | 5.79685068 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.75036842 |
| 27 | steroid catabolic process (GO:0006706) | 5.70245280 |
| 28 | bile acid metabolic process (GO:0008206) | 5.67704859 |
| 29 | serine family amino acid metabolic process (GO:0009069) | 5.62884025 |
| 30 | regulation of bile acid biosynthetic process (GO:0070857) | 5.45928187 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 5.37622262 |
| 32 | cellular glucuronidation (GO:0052695) | 5.36041815 |
| 33 | arginine metabolic process (GO:0006525) | 5.30982355 |
| 34 | bile acid and bile salt transport (GO:0015721) | 5.17528900 |
| 35 | glucuronate metabolic process (GO:0019585) | 5.16884852 |
| 36 | uronic acid metabolic process (GO:0006063) | 5.16884852 |
| 37 | triglyceride homeostasis (GO:0070328) | 5.01845323 |
| 38 | acylglycerol homeostasis (GO:0055090) | 5.01845323 |
| 39 | drug metabolic process (GO:0017144) | 4.97346203 |
| 40 | regulation of lipoprotein particle clearance (GO:0010984) | 4.94972455 |
| 41 | serine family amino acid biosynthetic process (GO:0009070) | 4.92974251 |
| 42 | proline metabolic process (GO:0006560) | 4.85115193 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.76958175 |
| 44 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.71912256 |
| 45 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.71912256 |
| 46 | negative regulation of complement activation (GO:0045916) | 4.71161043 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.55076804 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.55076804 |
| 49 | aldehyde catabolic process (GO:0046185) | 4.53468193 |
| 50 | negative regulation of hemostasis (GO:1900047) | 4.50191190 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.50191190 |
| 52 | cysteine metabolic process (GO:0006534) | 4.48750764 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.44573918 |
| 54 | drug transmembrane transport (GO:0006855) | 4.43537755 |
| 55 | regulation of sequestering of triglyceride (GO:0010889) | 4.39705384 |
| 56 | regulation of plasminogen activation (GO:0010755) | 4.37688458 |
| 57 | phospholipid efflux (GO:0033700) | 4.32643409 |
| 58 | heme transport (GO:0015886) | 4.26832659 |
| 59 | negative regulation of wound healing (GO:0061045) | 4.26521787 |
| 60 | protein activation cascade (GO:0072376) | 4.19628442 |
| 61 | L-serine metabolic process (GO:0006563) | 4.17409429 |
| 62 | cholesterol catabolic process (GO:0006707) | 4.11904237 |
| 63 | sterol catabolic process (GO:0016127) | 4.11904237 |
| 64 | negative regulation of coagulation (GO:0050819) | 4.09010795 |
| 65 | retinal metabolic process (GO:0042574) | 4.03031997 |
| 66 | arginine catabolic process (GO:0006527) | 4.02111116 |
| 67 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.92736533 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92355712 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.92355712 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.92355712 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.90706474 |
| 72 | negative regulation of lipase activity (GO:0060192) | 3.89688252 |
| 73 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89296727 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 3.86027705 |
| 75 | cofactor catabolic process (GO:0051187) | 3.81977065 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81363383 |
| 77 | regulation of humoral immune response (GO:0002920) | 3.77325170 |
| 78 | complement activation (GO:0006956) | 3.77058259 |
| 79 | midgut development (GO:0007494) | 3.73767798 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.71831287 |
| 81 | negative regulation of humoral immune response (GO:0002921) | 3.70371318 |
| 82 | glutamine family amino acid catabolic process (GO:0009065) | 3.68250140 |
| 83 | cellular aldehyde metabolic process (GO:0006081) | 3.67583595 |
| 84 | positive regulation of blood coagulation (GO:0030194) | 3.64828041 |
| 85 | positive regulation of hemostasis (GO:1900048) | 3.64828041 |
| 86 | acute-phase response (GO:0006953) | 3.61884697 |
| 87 | regulation of lipoprotein metabolic process (GO:0050746) | 3.56569112 |
| 88 | diterpenoid biosynthetic process (GO:0016102) | 3.55108049 |
| 89 | drug transport (GO:0015893) | 3.52648254 |
| 90 | omega-hydroxylase P450 pathway (GO:0097267) | 3.50546329 |
| 91 | dopamine biosynthetic process (GO:0042416) | 3.50086345 |
| 92 | acute inflammatory response (GO:0002526) | 3.49485725 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 3.44830714 |
| 94 | polyketide metabolic process (GO:0030638) | 3.44794091 |
| 95 | doxorubicin metabolic process (GO:0044598) | 3.44794091 |
| 96 | daunorubicin metabolic process (GO:0044597) | 3.44794091 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.44107545 |
| 98 | carnitine metabolic process (GO:0009437) | 3.41954086 |
| 99 | NADH metabolic process (GO:0006734) | 3.37070937 |
| 100 | glyoxylate metabolic process (GO:0046487) | 11.9363296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 8.09719410 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.07357059 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.68515028 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.82959197 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81382123 |
| 6 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.78085267 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.71537478 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.36586607 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.32008698 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.71555574 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.24308397 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4957129 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.96883466 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.78583956 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78306778 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63637622 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60818924 |
| 18 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.58962705 |
| 19 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.58501331 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53135306 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48961978 |
| 22 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.48446226 |
| 23 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.44416033 |
| 24 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.43944636 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.40102206 |
| 26 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.34851678 |
| 27 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.30209771 |
| 28 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.28477742 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24555442 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.22957902 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15835232 |
| 32 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.12622337 |
| 33 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.11421623 |
| 34 | NFYA_21822215_ChIP-Seq_K562_Human | 1.10573227 |
| 35 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.09901163 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06925042 |
| 37 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.05723349 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05109128 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04308080 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03841667 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02664828 |
| 42 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02571987 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01817578 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01768743 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01055271 |
| 46 | ERA_21632823_ChIP-Seq_H3396_Human | 1.00366035 |
| 47 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.99994208 |
| 48 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98958718 |
| 49 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98849182 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95103017 |
| 51 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92830931 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92629261 |
| 53 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92602992 |
| 54 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.92064984 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91812447 |
| 56 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.90970873 |
| 57 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90331597 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89440862 |
| 59 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87857829 |
| 60 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85449538 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85088178 |
| 62 | NFYB_21822215_ChIP-Seq_K562_Human | 0.84667737 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.83940033 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82552272 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81157018 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79487349 |
| 67 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78649061 |
| 68 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.78275170 |
| 69 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.77552380 |
| 70 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.77334649 |
| 71 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.76783731 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74650180 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.74453757 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74434531 |
| 75 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.74328938 |
| 76 | P300_27268052_Chip-Seq_Bcells_Human | 0.74132443 |
| 77 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72840680 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72502349 |
| 79 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72341453 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71737199 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.71671660 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.71577320 |
| 83 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.69970101 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69626289 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.69464899 |
| 86 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.69383006 |
| 87 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.69365439 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.68659041 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68468013 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.67767097 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67227313 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66527350 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.64802356 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.64266444 |
| 95 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63879313 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63581932 |
| 97 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.62753859 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.62753859 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.62581322 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62038843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22745368 |
| 2 | MP0005360_urolithiasis | 7.65708281 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 6.92813912 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.96981985 |
| 5 | MP0003868_abnormal_feces_composition | 5.86140059 |
| 6 | MP0009697_abnormal_copulation | 5.72242658 |
| 7 | MP0005365_abnormal_bile_salt | 5.11528893 |
| 8 | MP0003195_calcinosis | 4.23979570 |
| 9 | MP0002876_abnormal_thyroid_physiology | 3.39649644 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.31968418 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.31760935 |
| 12 | MP0003252_abnormal_bile_duct | 3.04441361 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.77001205 |
| 14 | MP0001764_abnormal_homeostasis | 2.49398238 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.08333013 |
| 16 | MP0010329_abnormal_lipoprotein_level | 1.85105375 |
| 17 | MP0005332_abnormal_amino_acid | 1.85072681 |
| 18 | MP0009840_abnormal_foam_cell | 1.82865652 |
| 19 | MP0005187_abnormal_penis_morphology | 1.68245746 |
| 20 | MP0010386_abnormal_urinary_bladder | 1.56134412 |
| 21 | MP0003186_abnormal_redox_activity | 1.46960599 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.33056694 |
| 23 | MP0000609_abnormal_liver_physiology | 1.31220060 |
| 24 | MP0005408_hypopigmentation | 1.29608636 |
| 25 | MP0002090_abnormal_vision | 1.16120279 |
| 26 | MP0001915_intracranial_hemorrhage | 1.13351365 |
| 27 | MP0005058_abnormal_lysosome_morphology | 0.94157624 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 0.93903762 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 0.90913952 |
| 30 | MP0000598_abnormal_liver_morphology | 0.90176202 |
| 31 | MP0003638_abnormal_response/metabolism_ | 0.87063266 |
| 32 | MP0005376_homeostasis/metabolism_phenot | 0.86444097 |
| 33 | MP0009643_abnormal_urine_homeostasis | 0.79023171 |
| 34 | MP0000604_amyloidosis | 0.78627469 |
| 35 | MP0002928_abnormal_bile_duct | 0.78041900 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77818471 |
| 37 | MP0005395_other_phenotype | 0.75033029 |
| 38 | MP0002132_abnormal_respiratory_system | 0.74071306 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.68688686 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.68234648 |
| 41 | MP0003959_abnormal_lean_body | 0.65294352 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.63751675 |
| 43 | MP0002822_catalepsy | 0.63219666 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 0.55089789 |
| 45 | MP0008874_decreased_physiological_sensi | 0.53109781 |
| 46 | MP0005410_abnormal_fertilization | 0.53076435 |
| 47 | MP0002089_abnormal_postnatal_growth/wei | 0.51890464 |
| 48 | MP0001986_abnormal_taste_sensitivity | 0.50336365 |
| 49 | MP0008469_abnormal_protein_level | 0.48381410 |
| 50 | MP0002168_other_aberrant_phenotype | 0.48182865 |
| 51 | MP0009672_abnormal_birth_weight | 0.47878460 |
| 52 | MP0009053_abnormal_anal_canal | 0.47655456 |
| 53 | MP0005266_abnormal_metabolism | 0.41578215 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 0.41432754 |
| 55 | MP0001661_extended_life_span | 0.40668548 |
| 56 | MP0009763_increased_sensitivity_to | 0.40451978 |
| 57 | MP0005535_abnormal_body_temperature | 0.40049016 |
| 58 | MP0001243_abnormal_dermal_layer | 0.39795527 |
| 59 | MP0003718_maternal_effect | 0.38639144 |
| 60 | MP0003879_abnormal_hair_cell | 0.38354101 |
| 61 | MP0005464_abnormal_platelet_physiology | 0.38179133 |
| 62 | MP0000249_abnormal_blood_vessel | 0.37087854 |
| 63 | MP0002971_abnormal_brown_adipose | 0.34782606 |
| 64 | MP0005197_abnormal_uvea_morphology | 0.32144797 |
| 65 | MP0003690_abnormal_glial_cell | 0.30414456 |
| 66 | MP0001324_abnormal_eye_pigmentation | 0.29528030 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.29477571 |
| 68 | MP0003698_abnormal_male_reproductive | 0.27788209 |
| 69 | MP0002161_abnormal_fertility/fecundity | 0.25297032 |
| 70 | MP0008873_increased_physiological_sensi | 0.25236754 |
| 71 | MP0003953_abnormal_hormone_level | 0.25129716 |
| 72 | MP0001929_abnormal_gametogenesis | 0.24019874 |
| 73 | MP0001440_abnormal_grooming_behavior | 0.23087530 |
| 74 | MP0003941_abnormal_skin_development | 0.21812958 |
| 75 | MP0002938_white_spotting | 0.21176108 |
| 76 | MP0000462_abnormal_digestive_system | 0.21075361 |
| 77 | MP0001845_abnormal_inflammatory_respons | 0.20800896 |
| 78 | MP0004272_abnormal_basement_membrane | 0.19444973 |
| 79 | MP0003699_abnormal_female_reproductive | 0.19138942 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 0.15945810 |
| 81 | MP0002060_abnormal_skin_morphology | 0.15927532 |
| 82 | MP0003646_muscle_fatigue | 0.15673735 |
| 83 | MP0005083_abnormal_biliary_tract | 0.15091432 |
| 84 | MP0000653_abnormal_sex_gland | 0.14907099 |
| 85 | MP0002970_abnormal_white_adipose | 0.14169705 |
| 86 | MP0004233_abnormal_muscle_weight | 0.13997619 |
| 87 | MP0003011_delayed_dark_adaptation | 0.13997518 |
| 88 | MP0000367_abnormal_coat/_hair | 0.13954786 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.13901833 |
| 90 | MP0002160_abnormal_reproductive_system | 0.12884191 |
| 91 | MP0005334_abnormal_fat_pad | 0.12856440 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.11302770 |
| 93 | MP0008872_abnormal_physiological_respon | 0.10809391 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.10444498 |
| 95 | MP0002697_abnormal_eye_size | 0.08582991 |
| 96 | MP0005452_abnormal_adipose_tissue | 0.08410501 |
| 97 | MP0009115_abnormal_fat_cell | 0.08316908 |
| 98 | MP0005164_abnormal_response_to | 0.08200429 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.07872066 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.07417316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 8.53086563 |
| 2 | Abnormality of pyrimidine metabolism (HP:0004353) | 7.51067501 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.27997978 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 6.50028454 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.15146623 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 5.78163851 |
| 7 | Cholecystitis (HP:0001082) | 5.47157442 |
| 8 | Abnormal gallbladder physiology (HP:0012438) | 5.47157442 |
| 9 | Joint hemorrhage (HP:0005261) | 5.03267997 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.64288392 |
| 11 | Complement deficiency (HP:0004431) | 4.62340841 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.52599118 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38139579 |
| 14 | Generalized aminoaciduria (HP:0002909) | 4.12689328 |
| 15 | Glomerulonephritis (HP:0000099) | 4.01584542 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.97155192 |
| 17 | Osteomalacia (HP:0002749) | 3.89792562 |
| 18 | Hyperammonemia (HP:0001987) | 3.89040980 |
| 19 | Abnormality of nucleobase metabolism (HP:0010932) | 3.61182790 |
| 20 | Abnormal pupillary function (HP:0007686) | 3.59075975 |
| 21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.59050821 |
| 22 | Bile duct proliferation (HP:0001408) | 3.57430792 |
| 23 | Abnormal biliary tract physiology (HP:0012439) | 3.57430792 |
| 24 | Xanthomatosis (HP:0000991) | 3.53527230 |
| 25 | Abnormality of complement system (HP:0005339) | 3.49167226 |
| 26 | Delayed CNS myelination (HP:0002188) | 3.15815626 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.13803788 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10572428 |
| 29 | Abnormality of serum amino acid levels (HP:0003112) | 3.07879693 |
| 30 | Pulmonary embolism (HP:0002204) | 2.96928956 |
| 31 | Sensorimotor neuropathy (HP:0007141) | 2.94650161 |
| 32 | Menorrhagia (HP:0000132) | 2.89943623 |
| 33 | Elevated alkaline phosphatase (HP:0003155) | 2.85722249 |
| 34 | Metabolic acidosis (HP:0001942) | 2.81901205 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 2.81650366 |
| 36 | Hyperglycinemia (HP:0002154) | 2.75032677 |
| 37 | Cholelithiasis (HP:0001081) | 2.66151978 |
| 38 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.60446216 |
| 39 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.55975463 |
| 40 | Abnormal gallbladder morphology (HP:0012437) | 2.50720104 |
| 41 | Abnormality of urine glucose concentration (HP:0011016) | 2.47253143 |
| 42 | Glycosuria (HP:0003076) | 2.47253143 |
| 43 | Cerebral edema (HP:0002181) | 2.44434394 |
| 44 | Hyperphosphaturia (HP:0003109) | 2.43663040 |
| 45 | Irritability (HP:0000737) | 2.38617280 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38191591 |
| 47 | Fat malabsorption (HP:0002630) | 2.37219326 |
| 48 | Atrioventricular block (HP:0001678) | 2.36303994 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34940051 |
| 50 | Abnormality of the Achilles tendon (HP:0005109) | 2.25642198 |
| 51 | Lethargy (HP:0001254) | 2.25006811 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24880246 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.24638759 |
| 54 | Fair hair (HP:0002286) | 2.23069524 |
| 55 | Purpura (HP:0000979) | 2.21235582 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.19068977 |
| 57 | Alkalosis (HP:0001948) | 2.15681231 |
| 58 | Nephritis (HP:0000123) | 2.15438949 |
| 59 | Gangrene (HP:0100758) | 2.14314861 |
| 60 | Spontaneous abortion (HP:0005268) | 2.13425002 |
| 61 | Decreased subcutaneous fat (HP:0001002) | 2.11666987 |
| 62 | Gingival bleeding (HP:0000225) | 2.11288523 |
| 63 | Arthropathy (HP:0003040) | 2.09942400 |
| 64 | Abnormal urine phosphate concentration (HP:0012599) | 2.08054278 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.07987181 |
| 66 | Increased serum ferritin (HP:0003281) | 2.05806146 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.04698790 |
| 68 | Potter facies (HP:0002009) | 2.04151557 |
| 69 | Facial shape deformation (HP:0011334) | 2.04151557 |
| 70 | Abnormality of the gallbladder (HP:0005264) | 2.02859157 |
| 71 | Hyperbilirubinemia (HP:0002904) | 2.01485417 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.01159786 |
| 73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01159786 |
| 74 | Deep venous thrombosis (HP:0002625) | 12.7234608 |
| 75 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.5341940 |
| 76 | Lower limb hyperreflexia (HP:0002395) | 1.98621713 |
| 77 | Beaking of vertebral bodies (HP:0004568) | 1.96538882 |
| 78 | Epidermoid cyst (HP:0200040) | 1.96482875 |
| 79 | Abnormality of the lower motor neuron (HP:0002366) | 1.95102969 |
| 80 | Steatorrhea (HP:0002570) | 1.94032840 |
| 81 | Goiter (HP:0000853) | 1.92412574 |
| 82 | Paraparesis (HP:0002385) | 1.92123492 |
| 83 | Retinal atrophy (HP:0001105) | 1.89274084 |
| 84 | Rickets (HP:0002748) | 1.87967440 |
| 85 | Prolonged neonatal jaundice (HP:0006579) | 1.86970253 |
| 86 | Abnormality of carpal bone ossification (HP:0006257) | 1.84729527 |
| 87 | Increased serum pyruvate (HP:0003542) | 1.84416452 |
| 88 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83975622 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 1.82485631 |
| 90 | Vomiting (HP:0002013) | 1.81569455 |
| 91 | Proximal tubulopathy (HP:0000114) | 1.80851827 |
| 92 | Pancreatitis (HP:0001733) | 1.79481243 |
| 93 | Achilles tendon contracture (HP:0001771) | 1.75690548 |
| 94 | Ketosis (HP:0001946) | 1.75333695 |
| 95 | Dyskinesia (HP:0100660) | 1.74736737 |
| 96 | Widely patent fontanelles and sutures (HP:0004492) | 1.74695181 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 1.74388269 |
| 98 | Polycythemia (HP:0001901) | 1.73031555 |
| 99 | Epiphyseal stippling (HP:0010655) | 1.67569789 |
| 100 | Acute encephalopathy (HP:0006846) | 1.67143796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 6.67393456 |
| 2 | PNCK | 4.55030553 |
| 3 | MET | 3.47789690 |
| 4 | BCKDK | 3.20166663 |
| 5 | MUSK | 2.94521751 |
| 6 | ARAF | 2.80994535 |
| 7 | MAP3K3 | 2.49338767 |
| 8 | CDK19 | 2.29685275 |
| 9 | MAP3K12 | 2.19864770 |
| 10 | PDK2 | 2.18600075 |
| 11 | BMX | 2.18499321 |
| 12 | TBK1 | 2.18264753 |
| 13 | MST1R | 2.13405276 |
| 14 | PRKCG | 2.11186583 |
| 15 | CASK | 2.04606889 |
| 16 | NEK1 | 1.89012372 |
| 17 | MAP2K3 | 1.77280654 |
| 18 | TAOK2 | 1.64158374 |
| 19 | PRKACG | 1.58187610 |
| 20 | TESK2 | 1.56095863 |
| 21 | CAMK1G | 1.53982249 |
| 22 | CDC7 | 1.53714874 |
| 23 | STK16 | 1.50209224 |
| 24 | WNK3 | 1.37184890 |
| 25 | ABL2 | 1.33612633 |
| 26 | MYLK | 1.23094392 |
| 27 | PINK1 | 1.18579562 |
| 28 | SGK1 | 1.15938915 |
| 29 | PRKCI | 1.14026183 |
| 30 | CSF1R | 1.11695266 |
| 31 | TESK1 | 1.03215305 |
| 32 | EIF2AK3 | 1.03208391 |
| 33 | BRAF | 1.02291833 |
| 34 | PTK2B | 1.00854372 |
| 35 | PIM2 | 1.00839412 |
| 36 | OXSR1 | 1.00503574 |
| 37 | MAP3K9 | 0.96861565 |
| 38 | PDPK1 | 0.93925693 |
| 39 | PRKG1 | 0.93877908 |
| 40 | CSNK1D | 0.93103334 |
| 41 | RIPK1 | 0.93082763 |
| 42 | PTK2 | 0.86355877 |
| 43 | TAOK3 | 0.85681724 |
| 44 | CDK4 | 0.81108626 |
| 45 | MAP2K2 | 0.80278659 |
| 46 | SCYL2 | 0.78985997 |
| 47 | FGFR4 | 0.78870661 |
| 48 | PRKACA | 0.78454736 |
| 49 | PRKCA | 0.78419854 |
| 50 | PRKCZ | 0.78253095 |
| 51 | FGR | 0.76690821 |
| 52 | PBK | 0.76662605 |
| 53 | GRK1 | 0.74516131 |
| 54 | PRPF4B | 0.73853690 |
| 55 | NEK9 | 0.71970678 |
| 56 | CAMKK1 | 0.71390363 |
| 57 | CSNK2A2 | 0.70012612 |
| 58 | STK38L | 0.66808252 |
| 59 | EPHA4 | 0.65908122 |
| 60 | MAP3K5 | 0.65602205 |
| 61 | DYRK2 | 0.63909824 |
| 62 | PLK1 | 0.63870933 |
| 63 | EIF2AK1 | 0.62830325 |
| 64 | CDK6 | 0.60639992 |
| 65 | CSNK2A1 | 0.57658298 |
| 66 | PDK1 | 0.56825547 |
| 67 | GRK6 | 0.55421771 |
| 68 | RPS6KA3 | 0.51818172 |
| 69 | INSRR | 0.50891959 |
| 70 | PRKCB | 0.50770766 |
| 71 | PRKCE | 0.50494612 |
| 72 | STK38 | 0.49877128 |
| 73 | AKT2 | 0.49733514 |
| 74 | LATS1 | 0.44674010 |
| 75 | PRKACB | 0.44401356 |
| 76 | DYRK3 | 0.43046721 |
| 77 | RAF1 | 0.42730691 |
| 78 | ERN1 | 0.40551881 |
| 79 | IGF1R | 0.36416147 |
| 80 | TNK2 | 0.35577185 |
| 81 | RPS6KA5 | 0.33445870 |
| 82 | PIK3CA | 0.32111202 |
| 83 | AURKA | 0.31655823 |
| 84 | CAMK2G | 0.30980882 |
| 85 | ZAK | 0.29761474 |
| 86 | MAP2K4 | 0.29723733 |
| 87 | CSNK1E | 0.29614249 |
| 88 | MAP3K11 | 0.29540728 |
| 89 | GSK3A | 0.29110562 |
| 90 | TTK | 0.29055378 |
| 91 | CDK11A | 0.29038420 |
| 92 | PLK4 | 0.28844832 |
| 93 | CSNK1A1 | 0.28350896 |
| 94 | NEK6 | 0.27688211 |
| 95 | MOS | 0.27682027 |
| 96 | PIM1 | 0.26804833 |
| 97 | CDK3 | 0.25732926 |
| 98 | RET | 0.24369291 |
| 99 | LIMK1 | 0.23107024 |
| 100 | SGK223 | 0.22388352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 5.10042610 |
| 2 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 4.09416026 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.71617360 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.37863199 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26363159 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.14247522 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.09999984 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.84235520 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.74294308 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.68136484 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.66328299 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63791790 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.49513420 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47574057 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.44747425 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 2.34875592 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 2.18295119 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.15052440 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.11577559 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77531805 |
| 21 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75218027 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.74258522 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.67163830 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.63264534 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54749320 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51478923 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51168263 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49414226 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.46157592 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44365746 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44157629 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42894581 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42348912 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40854687 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39261058 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37411783 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28386210 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22666364 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15738947 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10432302 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05777920 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01989569 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97128572 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88117162 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84014730 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83300954 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82408939 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81083952 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73786515 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73501893 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72524244 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69396830 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66770422 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65995600 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.58605803 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58003658 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56062086 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56033659 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55569204 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54203865 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.48360588 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44297130 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42601622 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41815886 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40555843 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40377126 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33771295 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.28107690 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27759018 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27477973 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23457042 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20555762 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20216966 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15334885 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.10019417 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.09146785 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.04542356 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03839774 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.03831692 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02021897 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00851020 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.1730548 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1660738 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1629712 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1602505 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1548910 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.1425760 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1405586 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1372613 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1222333 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1142759 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1082364 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0949324 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | -0.0930463 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | -0.0834162 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0636994 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0501001 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0482633 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0360459 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0116135 |

